Information Journal Paper
APA:
Copy. (2018). miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2). JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH, 37(1), 0-0. SID. https://sid.ir/paper/770006/en
Vancouver:
Copy. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2). JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH[Internet]. 2018;37(1):0-0. Available from: https://sid.ir/paper/770006/en
IEEE:
Copy, “miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2),” JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH, vol. 37, no. 1, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/770006/en